Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes

Recent studies suggest a pathogenetic association between metabolic disturbances, including type 2 diabetes (T2DM), and cognitive decline and indicate that T2DM may represent a risk factor for Alzheimer’s disease (AD). There are a number of experimental studies presenting evidence that ranolazine, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassano, Velia, Tallarico, Martina, Armentaro, Giuseppe, De Sarro, Caterina, Iannone, Michelangelo, Leo, Antonio, Citraro, Rita, Russo, Emilio, De Sarro, Giovambattista, Hribal, Marta Letizia, Sciacqua, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782607/
https://www.ncbi.nlm.nih.gov/pubmed/36555798
http://dx.doi.org/10.3390/ijms232416160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782607/
https://www.ncbi.nlm.nih.gov/pubmed/36555798
http://dx.doi.org/10.3390/ijms232416160

Ejemplares similares